Newsroom
Featured News
- Business26 July 2024
Lotus Pharmaceutical Honored 2024 Taiwan BIO Awards- Outstanding Company of the Year, Showcasing Excellence in Operational Performance, Development Strategy, and Technological Innovation
- Investors10 July 2024
Lotus Reported Unaudited June Revenues of NT$1,114 million
- Business05 July 2024
Lotus Pharmaceuticals Secures Three HR Asia Awards for 2024
- Investors07 June 2024
Lotus Reported Unaudited May Revenues of NT$1,553 million
- Business06 June 2024
Lotus Pharmaceuticals announces the acquisition of Teva Pharma Thailand, expanding its footprint in Southeast Asia
- Investors09 May 2024
Lotus announced 1Q24 financial results, full-year outlook unchanged
- Business06 May 2024
Lotus pharmaceuticals 1Q24 earnings call
- Investors10 April 2024
Lotus Reported Unaudited March Revenues of NT$1,151 million
- Investors08 March 2024
Lotus Reported Unaudited February Revenues of NT$1,052 Million